View Older Stories View More Recent Stories

Jan 9, 2023 06:05AM CORRECTING and REPLACING --Merus Provides 2023 Outlook
Jan 9, 2023 04:57AM Merus N.V. (MRUS) Provides 2023 Outlook
Jan 8, 2023 09:00AM Merus Provides 2023 Outlook
Jan 8, 2023 09:00AM Merus Provides 2023 Outlook
Nov 9, 2022 08:00AM Merus to Participate in a Fireside Chat at the Stifel 2022 Healthcare Conference
Nov 9, 2022 08:00AM Merus to Participate in a Fireside Chat at the Stifel 2022 Healthcare Conference
Nov 3, 2022 07:51AM Merus Announces Financial Results for the Third Quarter and Provides Business Update
Nov 3, 2022 07:51AM Merus Announces Financial Results for the Third Quarter and Provides Business Update
Oct 26, 2022 05:49AM Merus N.V. (MRUS) Presents First in Human Data on MCLA-129
Oct 26, 2022 04:00AM Merus Presents First in Human Data on MCLA-129 at the 34th EORTC/NCI/AACR (ENA) Symposium on Molecular Targets and Cancer Therapeutics
Oct 26, 2022 04:00AM Merus Presents First in Human Data on MCLA-129 at the 34th EORTC/NCI/AACR (ENA) Symposium on Molecular Targets and Cancer Therapeutics
Oct 12, 2022 07:00AM Merus Announces Publication of Abstract on MCLA-129 at the 34th EORTC/NCI/AACR (ENA) Symposium on Molecular Targets and Cancer Therapeutics
Oct 12, 2022 07:00AM Merus Announces Publication of Abstract on MCLA-129 at the 34th EORTC/NCI/AACR (ENA) Symposium on Molecular Targets and Cancer Therapeutics
Sep 7, 2022 04:10PM Merus Announces Poster Presentation on MCLA-129 at the 34th EORTC/NCI/AACR Symposium on Molecular Targets and Cancer Therapeutics
Sep 7, 2022 04:10PM Merus Announces Poster Presentation on MCLA-129 at the 34th EORTC/NCI/AACR Symposium on Molecular Targets and Cancer Therapeutics
Sep 1, 2022 08:00AM Merus to Participate in a Panel Discussion at Citi's 17th Annual BioPharma Conference
Sep 1, 2022 08:00AM Merus to Participate in a Panel Discussion at Citi's 17th Annual BioPharma Conference
Aug 8, 2022 04:17PM Merus Announces Financial Results for the Second Quarter and Provides Business Update
Aug 8, 2022 04:17PM Merus Announces Financial Results for the Second Quarter and Provides Business Update
Jun 6, 2022 05:48AM Merus N.V. (MRUS) Presents Clinical Data on Zenocutuzumab in NRG1-fusion (NRG1+) Cancer
Jun 5, 2022 11:00AM Merus Presents Clinical Data on Zenocutuzumab (Zeno) in NRG1-fusion (NRG1+) Cancer at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting (Oral Abstract)
Jun 5, 2022 11:00AM Merus Presents Clinical Data on Zenocutuzumab (Zeno) in NRG1-fusion (NRG1+) Cancer at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting (Oral Abstract)
Jun 3, 2022 08:00AM Merus to Participate in a Fireside Chat at the Jefferies Healthcare Conference
Jun 3, 2022 08:00AM Merus to Participate in a Fireside Chat at the Jefferies Healthcare Conference
May 26, 2022 05:00PM Merus Announces Publication of Abstract of Zenocutuzumab in NRG1-fusion (NRG1+) Cancer at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
May 26, 2022 05:00PM Merus Announces Publication of Abstract of Zenocutuzumab in NRG1-fusion (NRG1+) Cancer at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
May 17, 2022 08:00AM Merus to Present at the H.C. Wainwright Global Investment Conference
May 17, 2022 08:00AM Merus to Present at the H.C. Wainwright Global Investment Conference
May 9, 2022 04:29PM Merus Announces Financial Results for the First Quarter 2022 and Provides Business Update
May 9, 2022 04:29PM Merus Announces Financial Results for the First Quarter 2022 and Provides Business Update
Apr 27, 2022 04:01PM Zenocutuzumab Clinical Abstract Selected for Oral Presentation at the 2022 American Society of Clinical Oncology Annual Meeting
Apr 27, 2022 04:01PM Zenocutuzumab Clinical Abstract Selected for Oral Presentation at the 2022 American Society of Clinical Oncology Annual Meeting
Apr 25, 2022 08:00AM Merus Announces Publication in Nature Cancer on Petosemtamab’s (MCLA-158) Unique Mechanism of Action
Apr 25, 2022 08:00AM Merus Announces Publication in Nature Cancer on Petosemtamab’s (MCLA-158) Unique Mechanism of Action
Apr 8, 2022 01:00PM Merus Presents Preclinical Data on MCLA-129 at the American Association for Cancer Research Annual Meeting 2022
Apr 8, 2022 01:00PM Merus Presents Preclinical Data on MCLA-129 at the American Association for Cancer Research Annual Meeting 2022
Apr 6, 2022 08:00AM Merus to Participate in a Fireside Chat at the 21st Annual Needham Virtual Healthcare Conference
Apr 6, 2022 08:00AM Merus to Participate in a Fireside Chat at the 21st Annual Needham Virtual Healthcare Conference
Mar 8, 2022 04:35PM Merus Announces Publication of Abstract on MCLA-129 at the American Association for Cancer Research 2022 Annual Meeting
Mar 8, 2022 04:35PM Merus Announces Publication of Abstract on MCLA-129 at the American Association for Cancer Research 2022 Annual Meeting
Feb 28, 2022 04:36PM Merus Announces Financial Results for the Fourth Quarter and Full Year 2021 and Provides Business Update
Feb 28, 2022 04:36PM Merus Announces Financial Results for the Fourth Quarter and Full Year 2021 and Provides Business Update
Feb 3, 2022 08:00AM Merus to Participate in Upcoming Investor Conferences
Feb 3, 2022 08:00AM Merus to Participate in Upcoming Investor Conferences
Jan 25, 2022 04:32PM Merus N.V. (MRUS) Appoints Shannon Campbell as Chief Commercial Officer and Regains Worldwide Rights to MCLA-145
Jan 25, 2022 04:30PM Merus Appoints Shannon Campbell as Chief Commercial Officer and Regains Worldwide Rights to MCLA-145
Jan 25, 2022 04:30PM Merus Appoints Shannon Campbell as Chief Commercial Officer and Regains Worldwide Rights to MCLA-145
Dec 10, 2021 08:03AM Merus N.V. (MRUS) Presents Updates Analysis of Zenocutuzumab, Trastuzumab, and Vinorelbine in Patients with HER2+ Metastatic Breast Cancer
Dec 10, 2021 08:00AM Merus Presents Updated Analysis of Zenocutuzumab, Trastuzumab, and Vinorelbine in Patients with HER2+ Metastatic Breast Cancer at the San Antonio Breast Cancer Symposium
Dec 10, 2021 08:00AM Merus Presents Updated Analysis of Zenocutuzumab, Trastuzumab, and Vinorelbine in Patients with HER2+ Metastatic Breast Cancer at the San Antonio Breast Cancer Symposium
View More Recent Stories View Older Stories